BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou J, Li M, Wang X, He Y, Xia Y, Sweeney JA, Kopp RF, Liu C, Chen C. Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder. Front Neurosci 2021;15:674273. [PMID: 34054421 DOI: 10.3389/fnins.2021.674273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Castle D, Feusner J, Laposa JM, Richter PMA, Hossain R, Lusicic A, Drummond LM. Psychotherapies and digital interventions for OCD in adults: What do we know, what do we need still to explore? Compr Psychiatry 2023;120:152357. [PMID: 36410261 DOI: 10.1016/j.comppsych.2022.152357] [Reference Citation Analysis]
2 Cubillos S, Engmann O, Brancato A. BDNF as a Mediator of Antidepressant Response: Recent Advances and Lifestyle Interactions. Int J Mol Sci 2022;23. [PMID: 36430921 DOI: 10.3390/ijms232214445] [Reference Citation Analysis]
3 Mohammadi S, Beh-pajooh A, Ahmadimanesh M, Amini M, Ghazi-khansari M, Moallem SA, Hosseini R, Nourian YH, Ghahremani MH. Evaluation of DNA methylation in BDNF, SLC6A4, NR3C1 and FKBP5 before and after treatment with selective serotonin-reuptake inhibitor in major depressive disorder. Epigenomics 2022. [DOI: 10.2217/epi-2022-0246] [Reference Citation Analysis]
4 Bowler S, Papoutsoglou G, Karanikas A, Tsamardinos I, Corley MJ, Ndhlovu LC. A machine learning approach utilizing DNA methylation as an accurate classifier of COVID-19 disease severity. Sci Rep 2022;12:17480. [PMID: 36261477 DOI: 10.1038/s41598-022-22201-4] [Reference Citation Analysis]
5 Šalamon Arčan I, Kouter K, Videtič Paska A. Depressive disorder and antidepressants from an epigenetic point of view. World J Psychiatry 2022; 12(9): 1150-1168 [DOI: 10.5498/wjp.v12.i9.1150] [Reference Citation Analysis]
6 Han KM, Choi KW, Kim A, Kang W, Kang Y, Tae WS, Han MR, Ham BJ. Association of DNA Methylation of the NLRP3 Gene with Changes in Cortical Thickness in Major Depressive Disorder. Int J Mol Sci 2022;23:5768. [PMID: 35628578 DOI: 10.3390/ijms23105768] [Reference Citation Analysis]
7 Calabrò M, Fabbri C, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Serretti A, Crisafulli C. Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study. European Neuropsychopharmacology 2022;56:100-11. [DOI: 10.1016/j.euroneuro.2022.01.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang Y, Wang M, Zhang X, Jiang Z, Zhang Y, Fu X, Li Y, Cao D, Han J, Tong J, Teekaraman Y. Helicid Improves Lipopolysaccharide-Induced Apoptosis of C6 Cells by Regulating SH2D5 DNA Methylation via the CytC/Caspase9/Caspase3 Signaling Pathway. Contrast Media & Molecular Imaging 2022;2022:1-13. [DOI: 10.1155/2022/9242827] [Reference Citation Analysis]
9 Bandeira IC, Giombelli L, Werlang IC, Abujamra AL, Secchi TL, Brondani R, Bragatti JA, Bizzi JWJ, Leistner-Segal S, Bianchin MM. Methylation of BDNF and SLC6A4 Gene Promoters in Brazilian Patients With Temporal Lobe Epilepsy Presenting or Not Psychiatric Comorbidities. Front Integr Neurosci 2021;15:764742. [PMID: 34912196 DOI: 10.3389/fnint.2021.764742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Adanty C, Shakeri A, Strauss J, Graff A, De Luca V. Head-to-head comparison of various antipsychotic agents on genome-wide methylation in schizophrenia. Pharmacogenomics 2021. [PMID: 34787483 DOI: 10.2217/pgs-2021-0113] [Reference Citation Analysis]
11 de Witte LD, Wang Z, Snijders GLJL, Mendelev N, Liu Q, Sneeboer MAM, Boks MPM, Ge Y, Haghighi F. Contribution of Age, Brain Region, Mood Disorder Pathology, and Interindividual Factors on the Methylome of Human Microglia. Biol Psychiatry 2021:S0006-3223(21)01714-5. [PMID: 35027166 DOI: 10.1016/j.biopsych.2021.10.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Scherf-Clavel M, Weber H, Deckert J, Erhardt-Lehmann A. The role of pharmacogenetics in the treatment of anxiety disorders and the future potential for targeted therapeutics. Expert Opin Drug Metab Toxicol 2021;:1-12. [PMID: 34643143 DOI: 10.1080/17425255.2021.1991912] [Reference Citation Analysis]
13 Luo C, Pi X, Hu N, Wang X, Xiao Y, Li S, Sweeney JA, Bishop JR, Gong Q, Xie D, Lui S. Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function. Mol Psychiatry 2021. [PMID: 34588622 DOI: 10.1038/s41380-021-01308-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Xing Y, Sun T, Li G, Xu G, Cheng J, Gao S. The role of BDNF exon I region methylation in the treatment of depression with sertraline and its clinical diagnostic value. J Clin Lab Anal 2021;35:e23993. [PMID: 34528295 DOI: 10.1002/jcla.23993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Haga SB, Mills R, Moaddeb J, Liu Y, Voora D. Independent Community Pharmacists' Experience in Offering Pharmacogenetic Testing. Pharmgenomics Pers Med 2021;14:877-86. [PMID: 34290521 DOI: 10.2147/PGPM.S314972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]